CA
VIR icon

Cliff Asness’s Vir Biotechnology VIR Stock Holding History

Cliff Asness’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92M Buy
581,416
+15,407
+3% +$147K ﹤0.01% 1890
2026
Q1 		$5.07M Buy
566,009
+379,685
+204% +$3.03M ﹤0.01% 1741
2025
Q4 		$1.12M Buy
186,324
+34,186
+22% +$204K ﹤0.01% 2481
2025
Q3 		$869K Sell
152,138
-296,667
-66% -$1.52M ﹤0.01% 2519
2025
Q2 		$2.26M Buy
448,805
+180,508
+67% +$968K ﹤0.01% 1703
2025
Q1 		$1.74M Buy
268,297
+256,037
+2,088% +$2.28M ﹤0.01% 1686
2024
Q4 		$90K Sell
12,260
-4,662
-28% -$36.8K ﹤0.01% 2776
2024
Q3 		$127K Buy
16,922
+1,885
+13% +$16.4K ﹤0.01% 2632
2024
Q2 		$134K Sell
15,037
-11,022
-42% -$106K ﹤0.01% 2468
2024
Q1 		$264K Buy
26,059
+5,566
+27% +$56.7K ﹤0.01% 2173
2023
Q4 		$206K Sell
20,493
-69,382
-77% -$634K ﹤0.01% 2205
2023
Q3 		$842K Sell
89,875
-200,481
-69% -$2.86M ﹤0.01% 1660
2023
Q2 		$7.12M Sell
290,356
-47,316
-14% -$1.19M 0.02% 769
2023
Q1 		$7.86M Buy
337,672
+28,999
+9% +$742K 0.02% 723
2022
Q4 		$7.81M Sell
308,673
-44,060
-12% -$1.08M 0.02% 726
2022
Q3 		$6.8M Buy
352,733
+143,024
+68% +$3.64M 0.02% 748
2022
Q2 		$5.34M Buy
209,709
+100,139
+91% +$2.34M 0.01% 790
2022
Q1 		$2.82M Buy
+109,570
New +$3.25M 0.01% 1010
2021
Q4 		– Sell
-9,498
Closed -$413K – 2282
2021
Q3 		$413K Buy
+9,498
New +$411K ﹤0.01% 1935
2021
Q2 		– Sell
-12,111
Closed -$621K – 2304
2021
Q1 		$621K Buy
+12,111
New +$653K ﹤0.01% 1755
2020
Q4 		– Sell
-21,543
Closed -$740K – 2264
2020
Q3 		$740K Buy
+21,543
New +$928K ﹤0.01% 1566

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cliff Asness's VIR Position: Q2 2026 in Review

Cliff Asness increased its Vir Biotechnology (VIR) stake by 2.7% in Q2 2026, buying an estimated $147K and bringing the position to 581,416 shares worth $5.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Cliff Asness first reported a position in VIR in Q3 2020 and has held it in 21 quarters since. The position peaked at $7.86M in Q1 2023. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Cliff Asness held 581,416 shares of Vir Biotechnology worth $5.92M as of Q2 2026.
  • Cliff Asness bought 15,407 Vir Biotechnology shares in Q2 2026, an estimated $147K.
  • Vir Biotechnology made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1890 holding.
  • Cliff Asness first reported a position in Vir Biotechnology in Q3 2020 and has held it in 21 quarters since.
  • Cliff Asness's Vir Biotechnology position peaked at $7.86M in Q1 2023.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.